IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Salix Pharmaceuticals Inc

CUSIP: 795435956 | 8 institutional holders

Quarters

Q1 2015Q4 2014Q3 2014Q2 2014Q1 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile